Regenera Pharma

Israeli, clinical stage biopharma developing botanically-derived small molecule therapeutics for optic nerve disorders

placeNess Ziona, Center District, Israel calendar_todayFounded 2008 groups6 employees language regenerapharma.com

Innovation

14 patent families (10 granted) — focus: Human necessities; filing pace slowing. Cited 1,649 times.

YearFilings
20126
20133
20142
20157
20166
20177
20186
20197
20205
20217
20223

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon